Zobrazeno 1 - 10
of 64
pro vyhledávání: '"Gerry Lowe"'
Autor:
Peter Ostler, Peter Hoskin, Gerry Lowe, Hannah Tharmalingam, Robert Hughes, Roberto Alonzi, Y. Tsang, Shreya Armstrong
Publikováno v:
Radiotherapy and Oncology. 157:93-98
Purpose/objective Long-term follow up of single dose high-dose rate brachytherapy (HDR BT) for localised prostate cancer has revealed higher than expected rates of biochemical and local failure. This study aimed (i) to investigate the pattern of rela
Publikováno v:
Strahlentherapie und Onkologie. 197:547-554
This study compares the plan quality of high-dose-rate brachytherapy (HDR-BT) and volumetric modulated arc therapy (VMAT) for superficial irradiation of large areas of skin with significant curvature in one or more planes. A total of 14 patients from
Autor:
Christian Kirisits, Ina M. Jürgenliemk-Schulz, Bernard Oosterveld, Robert Hudej, Richard Pötter, Peter Bownes, Kees Koedooder, Gerry Lowe, Astrid de Leeuw, Jacob Christian Lindegaard, Marisol De Brabandere, Arun S Oinam, Monica Serban, Taran Paulsen Hellebust, Kari Tanderup, Anne Beate Langeland Marthinsen, Geetha Menon, Diane Whitney, Jamema Swamidas, Nicole Nesvacil
Publikováno v:
Serban, M, Kirisits, C, de Leeuw, A, Pötter, R, Jürgenliemk-Schulz, I, Nesvacil, N, Swamidas, J, Hudej, R, Lowe, G, Hellebust, T P, Menon, G, Oinam, A, Bownes, P, Oosterveld, B, De Brabandere, M, Koedooder, K, Langeland Marthinsen, A B, Whitney, D, Lindegaard, J, Tanderup, K & EMBRACE Collaborative Group 2020, ' Ring Versus Ovoids and Intracavitary Versus Intracavitary-Interstitial Applicators in Cervical Cancer Brachytherapy : Results From the EMBRACE I Study ', International Journal of Radiation Oncology Biology Physics, vol. 106, no. 5, pp. 1052-1062 . https://doi.org/10.1016/j.ijrobp.2019.12.019
International Journal of Radiation Oncology Biology Physics, 106(5), 1052-1062. Elsevier Inc.
International Journal of Radiation Oncology Biology Physics, 106(5), 1052-1062. Elsevier Inc.
Purpose: The aim of this study was to investigate the influence of brachytherapy technique and applicator type on target dose, isodose surface volumes, and organ-at-risk (OAR) dose. Methods and Materials: Nine hundred two patients treated with tandem
Autor:
Peter Ostler, Gerry Lowe, Robert Hughes, Roberto Alonzi, P. Chitmanee, Hannah Tharmalingam, Peter Hoskin, Y. Tsang, M. Hamada
Publikováno v:
Clinical Oncology. 32:259-265
Aims To evaluate focal high dose rate (HDR) brachytherapy in locally recurrent prostate cancer. Materials and methods Patients with biochemical relapse after non-surgical primary treatment for localised prostate cancer were selected after a negative
Autor:
Melissa Christiaens, Marisol De Brabandere, Taran Paulsen Hellebust, Janaki Hadjiev, Alina Sturdza, Ina M. Jürgenliemk-Schulz, Israel Fortin, Søren M. Bentzen, Kari Tanderup, Umesh Mahantshetty, Stefan Ecker, Deidre Batchelar, Stéphanie Smet, Kathrin Kirchheiner, Fleur Huang, Kenji Yoshida, Katarina Majercakova, Yusung Kim, Petra Georg, Anne Beate Langeland Marthinsen, Johannes Dimopoulos, Neamat Hegazy, Petra Trnkova, Arun S Oinam, Bernard Oosterveld, Primoz Petric, Beth Erickson, Gerry Lowe, Itxa Mora, Mario Federico, Jan-Erik Palmgren, Ludy C.H.W. Lutgens, Marianne S. Assenholt, Margit Valgma, Elzbieta van der Steen-Banasik, Karen S. Nkiwane, Kjersti Bruheim, Henrike Westerveld, Elena Fidarova, Bradley R. Pieters, Christian Kirisits, Richard Pötter, Lars Fokdal, Ian Dilworth, Susovan Banerjee, Marit Sundset, Robert Hudej, Geraldine Jacobson, Erik Van Limbergen, Maarit Anttila, Thomas Liederer, Isabelle Dumas, Elke Dörr, Pittaya Dankulchai, L.T. Tan, Jusheng An, Barbara Segedin, Jason Rownd, Christine Haie-Meder, Diane Whitney, Francois Bachand, Noha Jastaniyah, Martijn Ketelaars, Rachel Cooper, Peter Hoskin, Monica Serban, E. Villafranca, Nicole Nesvacil, Astrid de Leeuw, Hilde Janssen, Jacob Christian Lindegaard, Dina Najjari Jamal, Kees Koedooder, Cyrus Chargari, Maximilian Schmid, Gergely Antal, Thomas Berger, Robin Ristl, Remi A. Nout, Nina Boje Kibsgaard Jensen, Brigitte Reinniers, Tamara Diendorfer, Geetha Menon, Sofia Spampinato, Dragan Misimovic, Joyce Siu Yu Wong, Laura Motisi, Anders Schwartz-Vittrup, Bhavana Rai, Joanna Gora, Jamema Swamidas, Peter Bownes
Publikováno v:
Pötter, R, Tanderup, K, Schmid, M P, Jürgenliemk-Schulz, I, Haie-Meder, C, Fokdal, L U, Sturdza, A E, Hoskin, P, Mahantshetty, U, Segedin, B, Bruheim, K, Huang, F, Rai, B, Cooper, R, van der Steen-Banasik, E, Van Limbergen, E, Pieters, B R, Tan, L T, Nout, R A, De Leeuw, A A C, Ristl, R, Petric, P, Nesvacil, N, Kirchheiner, K, Kirisits, C, Lindegaard, J C & EMBRACE Collaborative Group 2021, ' MRI-guided adaptive brachytherapy in locally advanced cervical cancer (EMBRACE-I) : a multicentre prospective cohort study ', The Lancet Oncology, vol. 22, no. 4, pp. 538-547 . https://doi.org/10.1016/S1470-2045(20)30753-1
The Lancet Oncology, 22(4), 538-547. Lancet Publishing Group
lancet oncology, 22(4), 538-547. Lancet Publishing Group
The Lancet Oncology, 22(4), 538-547. Lancet Publishing Group
lancet oncology, 22(4), 538-547. Lancet Publishing Group
Background: The concept of the use of MRI for image-guided adaptive brachytherapy (IGABT) in locally advanced cervical cancer was introduced 20 years ago. Here, we report on EMBRACE-I, which aimed to evaluate local tumour control and morbidity after
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::80c5b5ad754a052b2afe05b1e7536075
https://doi.org/10.5167/uzh-215991
https://doi.org/10.5167/uzh-215991
Autor:
Geetha Menon, Gerry Lowe, Remi A. Nout, Astrid de Leeuw, Christian Kirisits, Kari Tanderup, Dietmar Georg, Marianne S. Assenholt, Richard Pötter, Lars Fokdal, Robert Hudej, Thomas Berger, Ina M. Jürgenliemk-Schulz, Isabelle Dumas, Jamema Swamidas, Li Tee Tan, Jacob Christian Lindegaard, Taran Paulsen Hellebust, Nicole Nesvacil, Y. Seppenwoolde
Publikováno v:
International Journal of Radiation Oncology Biology Physics, 104(4), 885-894. Elsevier Inc.
Berger, T, Seppenwoolde, Y, Pötter, R, Assenholt, M S, Lindegaard, J C, Nout, R A, de Leeuw, A, Jürgenliemk-Schulz, I, Tan, L T, Georg, D, Kirisits, C, Dumas, I, Nesvacil, N, Swamidas, J, Hudej, R, Lowe, G, Hellebust, T P, Menon, G, Fokdal, L, Tanderup, K & EMBRACE Collaborative Group 2019, ' Importance of Technique, Target Selection, Contouring, Dose Prescription, and Dose-Planning in External Beam Radiation Therapy for Cervical Cancer : Evolution of Practice From EMBRACE-I to II ', International Journal of Radiation Oncology Biology Physics, vol. 104, no. 4, pp. 885-894 . https://doi.org/10.1016/j.ijrobp.2019.03.020
Berger, T, Seppenwoolde, Y, Pötter, R, Assenholt, M S, Lindegaard, J C, Nout, R A, de Leeuw, A, Jürgenliemk-Schulz, I, Tan, L T, Georg, D, Kirisits, C, Dumas, I, Nesvacil, N, Swamidas, J, Hudej, R, Lowe, G, Hellebust, T P, Menon, G, Fokdal, L, Tanderup, K & EMBRACE Collaborative Group 2019, ' Importance of Technique, Target Selection, Contouring, Dose Prescription, and Dose-Planning in External Beam Radiation Therapy for Cervical Cancer : Evolution of Practice From EMBRACE-I to II ', International Journal of Radiation Oncology Biology Physics, vol. 104, no. 4, pp. 885-894 . https://doi.org/10.1016/j.ijrobp.2019.03.020
Purpose To describe the evolution of external beam radiation therapy (EBRT) from EMBRACE-I (general guidelines for EBRT) to the initial phase of the EMBRACE-II study (detailed protocol for EBRT). Methods and Materials EMBRACE-I enrolled 1416 locally
Publikováno v:
Hoskin, P J, Rojas, A M, Ostler, P J, Bryant, L & Lowe, G J 2021, ' Randomised trial of external-beam radiotherapy alone or with high-dose-rate brachytherapy for prostate cancer: Mature 12-year results ', Radiotherapy and Oncology, vol. 154, pp. 214-219 . https://doi.org/10.1016/j.radonc.2020.09.047
Background and purpose A randomised phase-III trial compared external beam radiotherapy (EBRT) alone with EBRT combined with high-dose-rate brachytherapy boost (HDR-BTb) in localised prostate adenocarcinoma. Previous analysis, at median follow up of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be951920813cda5218ff702d849030a3
https://www.thegreenjournal.com/action/showPdf?pii=S0167-8140(20)30822-7
https://www.thegreenjournal.com/action/showPdf?pii=S0167-8140(20)30822-7
Publikováno v:
Brachytherapy. 20(2)
Purpose A potential late side effect of high-dose-rate (HDR) prostate brachytherapy combined with external beam radiotherapy (EBRT) is urethral stricture. The purpose of this study was to evaluate dosimetric parameters possibly contributing to strict
Publikováno v:
Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]. 197(6)
This study compares the plan quality of high-dose-rate brachytherapy (HDR-BT) and volumetric modulated arc therapy (VMAT) for superficial irradiation of large areas of skin with significant curvature in one or more planes.A total of 14 patients from
Publikováno v:
Brachytherapy. 17:181-186
Purpose Image-guided plan optimization with MRI and CT for interstitial and intracavitary brachytherapy is an established technique in treating cervical cancer. The purpose of this study was to assess the feasibility of boosting the dose to the resid